ARBELE CORP.
Arbele focuses on acceleration and expansion of immunotherapy technology and product development to treat cancers prevalent in Greater China, Asia-Pacific region and the United States. The company has established a stellar collaboration network with leading academic institutes, biotechs, and medical centers to progress the clinical stages of drug candidates. The company is founded by reputable scientists and senior executives in drug industries and recently teamed up with experienced professionals in financing, legal and investment.
ARBELE CORP.
Industry:
Biotechnology Health Care Health Diagnostics Medical Pharmaceutical
Founded:
2016-09-30
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.arbelebio.com
Total Employee:
11+
Status:
Active
Contact:
6174168636
Email Addresses:
[email protected]
Technology used in webpage:
Euro Microsoft
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.arbelebio.com Semrush global rank: 10.37 M Semrush visits lastest month: 233
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Arbele Corp."
About Us — ArbeleBio
John is a distinguished leader in biotechnology, bringing a wealth of expertise to our company. Over an illustrious 18-year academic career, he served as a professor in the US, Hong Kong, …See details»
Harnessing Cadherin-17 for Solid Tumours — ArbeleBio
Arbele Limited is a biotech company that specialises in treatment of gastrointestinal cancers. Arbele pioneered the use of CDH17 biomarker that targets solid tumours together with Tibtech …See details»
Arbele Corp. - Crunchbase Company Profile & Funding
Arbele Corp is a biotech R&D company focusing on next-gen immunotherapeutic platforms to treat cancer of high mortalitySee details»
Arbele Company Profile | Management and Employees List
Www.arbelebio.com Arbele Profile and History Founded in 2016, Arbele is a biopharmaceutical company dedicated to improving the lives of cancer patients by developing therapies for rare …See details»
Arbele Limited - HKSTP
Arbele is a locally grown pharmaceutical biotech with over 30 scientists and staff focused on immunotherapy of advanced gastrointestinal cancers with a high mortality rate (such as liver, …See details»
Arbele Corp. - Work in biotech
Arbele Corp. is focused on developing innovative immunotherapies for the treatment of gastrointestinal cancers and other solid tumors. Arbele has a suite of therapeutics including …See details»
About Us – ArbeleBio
Our Focus. Our Focus Gastrointestinal Cancers Gastrointestinal cancers presents a pressing challenge marked by unmet medical needs. Stomach, pancreas, colon, bile duct, and liver …See details»
Arbele Corp. - Drug pipelines, Patents, Clinical trials - Synapse
Mar 8, 2025 www.arbelebio.com. Startups | Private Company | 2016 | Washington, United States | 10-50 | www.arbelebio.com. Last update 08 Mar 2025. Overview. Pipeline. Deal. …See details»
Arbele - VentureRadar
Arbele is a biotech and biopharmaceutical company focused on invention of proprietary immunotherapeutic platforms to accelerate the development of... ... Find out ...See details»
Arbele 2025 Company Profile: Valuation, Funding
Arbele General Information Description. Operator of a biotechnology and biopharmaceutical company dedicated to offer the breakthrough targeted immunotherapeutic medicines to cure GI cancers (colon, stomach, pancreas, …See details»
Arbele - Overview, News & Similar companies | ZoomInfo.com
Aug 2, 2023 Who is Arbele. Founded in 2016, Arbele is a biopharmaceutical company dedicated to improving the lives of cancer patients by developing therapies for rare and har d-to-treat …See details»
ArbeleBio
The Asian Fund for Cancer Research (AFCR) is a non-profit organization committed to curing cancers that have significant impacts on Asian populations. Headquartered in Hong Kong, …See details»
Arbele Announces Strategic Collaborations on AI Precision …
Oct 9, 2024 Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics. SEATTLE, Oct. 9, 2024 …See details»
Arbele celebrates its 7th anniversary as a clinical-stage …
SEATTLE, May 5, 2023 /PRNewswire/ -- Arbele, a biotechnology company dedicated to fighting gastrointestinal cancers, celebrates its 7 th anniversary and the opening of Tiberias …See details»
Immunotherapy for Cancer Treatment — ArbeleBio
Arbele's research includes novel targets, T-cell engagers (TCE), antibody drug conjugate (ADC), cancer therapeutics, cancer immunotherapy, precision medicine, diagnostics (including blood …See details»
Arbele announces early safety data for novel CDH17xCD3 …
SYDNEY, Aug. 2, 2023 /PRNewswire/ -- Arbele, a clinical-stage biotechnology company developing novel immunotherapies targeted for advanced gastrointestinal cancers, presented …See details»
Arbele Announces Strategic Collaborations on AI Precision …
SEATTLE, Oct. 9, 2024 /PRNewswire/ -- Arbele, a leading innovator in biopharmaceutical & biotechnology focused on targeting cadherin-17 (CDH17), is pleased to announce strategic …See details»
BioAI Announces Strategic Partnership with Arbele Bio to Advance ...
Sep 30, 2024 BioAI, an emerging biotech company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, has announced a strategic …See details»
ArbeleBio
SEATTLE, Oct. 9, 2024 /PRNewswire/ -- Arbele, a leading innovator in biopharmaceutical & biotechnology focused on targeting cadherin-17 (CDH17), is pleased to announce strategic …See details»
News - ArbeleBio
Aug 2, 2024 The latest news from Arbele. SEATTLE, Oct. 9, 2024 /PRNewswire/ -- Arbele, a leading innovator in biopharmaceutical & biotechnology focused on targeting cadherin-17 …See details»